Last reviewed · How we verify

NCT05052450

Factors Associated With Mortality, Morbidity and Prognosis in Dementia Patients

Completed Last updated 22 September 2021
What this trial tests

trial testing Observational in Dementia in 1,000 participants. Completed in 31 December 2020.

Timeline
1 January 2000
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorGulhane Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 January 2000
Primary completion31 December 2020
Estimated completion31 December 2020

Drugs / interventions tested

Conditions studied

Sponsor

Gulhane Training and Research Hospital

Who can join

60 and older, any sex, with Dementia or Dementia, Vascular. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dementia; It is a chronic syndrome characterized by a general and progressive deterioration in cognition, including memory, orientation, language, and comprehension. The prognosis of this progressive and neurodegenerative disease after diagnosis may differ between individuals. In its broadest sense, the prognosis after a diagnosis of dementia; can be defined by shortening of life span, high level of cognitive and functional loss, decrease in quality of life and increased need for care. However, the prognosis of different types of dementia is highly variable. Because it is the most common type of dementia, studies are usually on Alzheimer's disease. It constitutes 50-75% of total dementia cases. Vascular dementia is the second most common cause of dementia and accounts for approximately 15% of dementia cases. Dementia with Lewy bodies constitutes 10-20% of the total dementia patients and ranks second among degenerative dementia types. Frontotemporal dementia, which mimics psychiatric disorders and has prominent behavioural problems, and Parkinson's disease-associated dementia, which is characterized by cognitive impairment that can be added to the existing picture in Parkinson's patients, are also counted among other types of dementia. Prognosis-related data on dementia types other than Alzheimer's disease are limited in the literature. Determining the prognosis is important to support patients, anticipate long-term health problems, plan physician and healthcare provision, and support patients with dementia.In view of the lack of sufficient data on dementia types other than Alzheimer's disease, it is aimed to contribute to the literature on this subject and to determine the factors that may affect prognosis, morbidity and mortality in patients belonging to all dementia types.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Assessment of clinical features and coexisting geriatric syndromes in newly diagnosed dementia with Lewy bodies: a retrospective study in a tertiary geriatrics setting in Turkey.
    Naharci MI, Kayahan Satis N, Ozsurekci C, Tasci I. · · 2023 · cited 6× · PMID 36512254 · DOI 10.1007/s41999-022-00727-0

Verify or expand the search:

Other trials of Observational

Trials testing the same drug.

Other recruiting trials for Dementia

Currently open trials in the same condition.

Other Gulhane Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05052450.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing